Tamoxifen improves homeostasis in the peri-implant bone remodeling of osseointegrated titanium implants
- PMID: 35856857
- DOI: 10.1111/jre.13026
Tamoxifen improves homeostasis in the peri-implant bone remodeling of osseointegrated titanium implants
Abstract
Background: The purpose of this preclinical study was to evaluate the influence of tamoxifen (TAM) on the peri-implant bone remodeling of osseointegrated titanium implants in ovariectomized female rats.
Materials and methods: Seventy-two female rats underwent bilateral ovariectomy 20 weeks before implants placement. One titanium implant was inserted in each tibia of the animals. Six weeks following the implant surgery, animals were randomly divided into two experimental groups (n = 36), which received either saline solution (SS) or tamoxifen citrate (TAM) via gavage until euthanasia. Euthanasia was performed at 30, 60, and 90 days after the first gavage. Assessments of bone to implant contact (BIC), bone ingrowth percentage (BIN), morphological description of cellular and tissue reactions, immunohistochemistry for the detection of bone morphogenetic protein 2/4 (BMP2/4), runt-related transcription factor 2 (RUNX-2), osteocalcin (OCN) and tartrate-resistant acid phosphatase (TRAP), and bone chemical composition through scanning electron microscopy with energy-dispersive x-ray spectroscopy were performed.
Results: Tamoxifen group presented higher BIC, higher BIN, higher RUNX-2 and OCN, lower TRAP-positive cells/mm2 , and no differences regarding BMP-2/4 positive cells/mm2 than SS group in all periods. TAM group also showed higher Ca/P rate than SS group.
Conclusion: Tamoxifen enhanced the remodeling of the bone surrounding titanium implants in ovariectomized rats.
Keywords: bone remodeling; dental implants; selective estrogen receptor modulators; tamoxifen.
© 2022 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.
Similar articles
-
The influence of antineoplastic agents on the peri-implant bone around osseointegrated titanium implants: an in vivo histomorphometric and immunohistochemical study.Clin Oral Investig. 2022 Mar;26(3):2681-2692. doi: 10.1007/s00784-021-04239-2. Epub 2021 Oct 23. Clin Oral Investig. 2022. PMID: 34686918
-
Cisplatin chemotherapy impairs the peri-implant bone repair around titanium implants: An in vivo study in rats.J Clin Periodontol. 2018 Feb;45(2):241-252. doi: 10.1111/jcpe.12824. Epub 2017 Dec 5. J Clin Periodontol. 2018. PMID: 28965362
-
Enhancing osseointegration of titanium implants through large-grit sandblasting combined with micro-arc oxidation surface modification.J Mater Sci Mater Med. 2019 Jun 11;30(6):73. doi: 10.1007/s10856-019-6276-0. J Mater Sci Mater Med. 2019. PMID: 31187259
-
Biological Response to Recombinant Human Bone Morphogenetic Protein-2 on Bone-Implant Osseointegration in Ovariectomized Experimental Design.J Craniofac Surg. 2019 Jan;30(1):141-144. doi: 10.1097/SCS.0000000000004992. J Craniofac Surg. 2019. PMID: 30616310
-
Osseointegration of titanium, titanium alloy and zirconia dental implants: current knowledge and open questions.Periodontol 2000. 2017 Feb;73(1):22-40. doi: 10.1111/prd.12179. Periodontol 2000. 2017. PMID: 28000277 Review.
Cited by
-
Impact of Titanium Plate Fixation on Diacylglycerol and Growth Factor Levels in the Periosteum of the Mandible and Maxilla in Patients with Dentofacial Deformities After Jaw Osteotomies.Int J Mol Sci. 2025 Feb 26;26(5):2020. doi: 10.3390/ijms26052020. Int J Mol Sci. 2025. PMID: 40076643 Free PMC article.
-
Behavior of Osteoblastic Lineage Cells When in the Presence of Tamoxifen: In Vitro and In Vivo Studies on Osseointegration.Dent J (Basel). 2025 Aug 1;13(8):351. doi: 10.3390/dj13080351. Dent J (Basel). 2025. PMID: 40863054 Free PMC article.
-
"Metal-bone" scaffold for accelerated peri-implant endosseous healing.Front Bioeng Biotechnol. 2024 Jan 10;11:1334072. doi: 10.3389/fbioe.2023.1334072. eCollection 2023. Front Bioeng Biotechnol. 2024. PMID: 38268934 Free PMC article.
References
REFERENCES
-
- Davies C, Pan H, Godwin J, et al. Long-term effects of continuing adjuvant tamoxifen to 10 years versus stopping at 5 years after diagnosis of oestrogen receptor-positive breast cancer: ATLAS, a randomised trial. Lancet. 2013;381(9869):805-816.
-
- Ribnikar D, Sousa B, Cufer T, Cardoso F. Extended adjuvant endocrine therapy - A standard to all or some? Breast. 2017;32:112-118.
-
- Moon LY, Wakley GK, Turner RT. Dose-dependent effects of tamoxifen on long bones in growing rats: influence of ovarian status. Endocrinology. 1991;129(3):1568-1574.
-
- Zidan J, Keidar Z, Basher W, Israel O. Effects of tamoxifen on bone mineral density and metabolism in postmenopausal women with early-stage breast cancer. Med Oncol. 2004;21(2):117-121.
-
- Hadji P, Ziller M, Kieback DG, et al. The effect of exemestane or tamoxifen on markers of bone turnover: results of a German sub-study of the Tamoxifen Exemestane Adjuvant Multicentre (TEAM) trial. Breast. 2009;18(3):159-164.
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Miscellaneous